Treatment with recombinant IL‐10 has shown to pronounce STm replication in MDMs,[66] while disruption of the IL‐10 receptor led to impaired phagocytosis.[67] Altogether, our immunocompetent model would offer a platform for the better understanding and further characterization of the cytokine milieu during early STm infection. This evidence concerns the gene IL10 and infection.